As RWE continues to influence the future of drug development, pharma companies will inevitably encounter hurdles. But with the right approach, they can be overcome to unlock critical insights and bring better therapies to patients faster.
The post Harnessing RWE for Post-Pandemic Healthcare: Accelerating Drug Development with Real-World Data appeared first on MedCity News.
